Peracetic acid treatment generates potent inactivated oral vaccines from a broad range of culturable bacterial species

Frontiers in Immunology

Volumn 7, Issue FEB, 2016, Pages

  Moor, Kathrin ^a   Wotzka, Sandra Y ^a   Toska, Albulena ^a   Diard, Médéric ^a   Hapfelmeier, Siegfried ^b   Slack, Emma ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

IgA; Inactivated vaccines; Oral vaccines; Salmonella typhimurium; Yersina enterocolytica

Indexed keywords

INACTIVATED VACCINE; PERACETIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHRONIC GRANULOMATOUS DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 84962535334     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00034     Document Type: Article

References (69)

1. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 5:520. doi: 10.3389/fimmu.2014.00520.
2. Bournazos S, DiLillo DJ, Ravetch JV. The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization. J Exp Med (2015) 212(9):1361-9. doi:10.1084/jem.20151267.
3. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol (2015) 16(4):343-53. doi:10.1038/ni.3123.
4. Wiesel M, Oxenius A. From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol (2012) 42(5):1080-8. doi:10.1002/eji.201142205.
5. Tubo NJ, Jenkins MK. CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev (2014) 27(2):200-13. doi:10.1128/CMR.00097-13.
6. Thammavongsa V, Kim HK, Missiakas D, Schneewind O. Staphylococcal manipulation of host immune responses. Nat Rev Microbiol (2015) 13(9):529-43. doi:10.1038/nrmicro3521.
7. Slack E, Balmer ML, Macpherson AJ. B cells as a critical node in the microbiota-host immune system network. Immunol Rev (2014) 260(1):50-66. doi:10.1111/imr.12179.
8. Azegami T, Yuki Y, Kiyono H. Challenges in mucosal vaccines for the control of infectious diseases. Int Immunol (2014) 26(9):517-28. doi:10.1093/intimm/dxu063.
9. Marcobal A, Kashyap PC, Nelson TA, Aronov PA, Donia MS, Spormann A, et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J (2013) 7(10):1933-43. doi:10.1038/ismej.2013.89.
10. Stecher B, Berry D, Loy A. Colonization resistance and microbial ecophysiology: using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle. FEMS Microbiol Rev (2013) 37(5):793-829. doi:10.1111/1574-6976.12024.
11. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science (2012) 336(6086):1268-73. doi:10.1126/science.1223490.
12. Macpherson AJ, McCoy KD. Stratification and compartmentalisation of immunoglobulin responses to commensal intestinal microbes. Semin Immunol (2013) 25(5):358-63. doi:10.1016/j.smim.2013.09.004.
13. Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 328(5986):1705-9. doi:10.1126/science.1188454.
14. Moor K, Slack E. What makes a bacterial oral vaccine a strong inducer of high-affinity IgA responses? Antibodies (2015) 4(4):295. doi:10.3390/antib4040295.
15. Cheminay C, Hensel M. Rational design of Salmonella recombinant vaccines. Int J Med Microbiol (2008) 298(1-2):87-98. doi:10.1016/j.ijmm.2007.08.006.
16. Wang S, Curtiss R III. Development of vaccines using live vectors. Vaccines (Basel) (2014) 2(1):49-88. doi:10.3390/vaccines2010049.
17. Abd El Ghany M, Jansen A, Clare S, Hall L, Pickard D, Kingsley RA, et al. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines. Infect Immun (2007) 75(4):1835-42. doi:10.1128/iai.01655-06.
18. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog (2010) 6(9):e1001097. doi:10.1371/journal.ppat.1001097.
19. Matsui H, Isshiki Y, Eguchi M, Ogawa Y, Shimoji Y. Evaluation of the live vaccine efficacy of virulence plasmid-cured, and phoP-or aroA-deficient Salmonella enterica serovar Typhimurium in mice. J Vet Med Sci (2015) 77(2):181-6. doi:10.1292/jvms.14-0013.
20. Peters SE, Paterson GK, Bandularatne ES, Northen HC, Pleasance S, Willers C, et al. Salmonella enterica serovar Typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261. Infect Immun (2009) 78(1):326-36. doi:10.1128/IAI.00768-09.
21. Galen JE, Curtiss R III. The delicate balance in genetically engineering live vaccines. Vaccine (2014) 32(35):4376-85. doi:10.1016/j.vaccine.2013.12.026.
22. Kaiser P, Regoes RR, Dolowschiak T, Wotzka SY, Lengefeld J, Slack E, et al. Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol (2014) 12(2):e1001793. doi:10.1371/journal.pbio.1001793.
23. Stecher B, Chaffron S, Kappeli R, Hapfelmeier S, Freedrich S, Weber TC, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog (2010) 6(1):e1000711. doi:10.1371/journal.ppat.1000711.
24. Manohar M, Baumann DO, Bos NA, Cebra JJ. Gut colonization of mice with actA-negative mutant of Listeria monocytogenes can stimulate a humoral mucosal immune response. Infect Immun (2001) 69(6):3542-9. doi:10.1128/IAI.69.6.3542-3549.2001.
25. Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun (1995) 63(10):3904-13.
26. Talham GL, Jiang HQ, Bos NA, Cebra JJ. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun (1999) 67(4):1992-2000.
27. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 303(5664):1662-5. doi:10.1126/science.1091334.
28. Wang S, Kong Q, Curtiss R III. New technologies in developing recombinant attenuated Salmonella vaccine vectors. Microb Pathog (2012) 58:17-28. doi:10.1016/j.micpath.2012.10.006.
29. Walker RI. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine (2005) 23(26):3369-85. doi:10.1016/j.vaccine.2004.12.029.
30. Kabir S. Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Clin Vaccine Immunol (2014) 21(9):1195-205. doi:10.1128/cvi.00378-14.
31. Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, et al. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled phase I study. Vaccine (2014) 32(52):7077-84. doi:10.1016/j.vaccine.2014.10.069.
32. McKenzie R, Walker RI, Nabors GS, Van De Verg LL, Carpenter C, Gomes G, et al. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine (2006) 24(18):3735-45. doi:10.1016/j.vaccine.2005.07.014.
33. Sudhaus N, Pina-Perez MC, Martinez A, Klein G. Inactivation kinetics of spores of Bacillus cereus strains treated by a peracetic acid-based disinfectant at different concentrations and temperatures. Foodborne Pathog Dis (2012) 9(5):442-52. doi:10.1089/fpd.2011.1043.
34. Chen X, Bauermeister LJ, Hill GN, Singh M, Bilgili SF, McKee SR. Efficacy of various antimicrobials on reduction of Salmonella and campylobacter and quality attributes of ground chicken obtained from poultry parts treated in a postchill decontamination tank. J Food Prot (2014) 77(11):1882-8. doi:10.4315/0362-028X.JFP-14-114.
35. Park E, Lee C, Bisesi M, Lee J. Efficiency of peracetic acid in inactivating bacteria, viruses, and spores in water determined with ATP bioluminescence, quantitative PCR, and culture-based methods. J Water Health (2014) 12(1):13-23. doi:10.2166/wh.2013.002.
36. Kaiser P, Diard M, Stecher B, Hardt WD. The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response. Immunol Rev (2011) 245(1):56-83. doi:10.1111/j.1600-065X.2011.01070.x.
37. Felmy B, Songhet P, Slack EM, Muller AJ, Kremer M, Van Maele L, et al. NADPH oxidase deficient mice develop colitis and bacteremia upon infection with normally avirulent, TTSS-1-and TTSS-2-deficient Salmonella typhimurium. PLoS One (2013) 8(10):e77204. doi:10.1371/journal.pone.0077204.
38. Chen J, Troustine M, Alt F, Young F, Kurahara C, Loring J, et al. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol (1993) 5(6):647-56. doi:10.1093/intimm/5.6.647.
39. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet (1995) 9(2):202-9. doi:10.1038/ng0295-202.
40. Harriman GR, Bogue M, Rogers P, Finegold M, Pacheco S, Bradley A, et al. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol (1999) 162(5):2521-9.
41. Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 360(6401):225-31. doi:10.1038/360225a0.
42. Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M, Hardt WD. Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun (2004) 72(2):795-809. doi:10.1128/IAI.72.2.795-809.2004.
43. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 291(5812):238-9. doi:10.1038/291238a0.
44. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun (2003) 71(5):2839-58. doi:10.1128/IAI.71.5.2839-2858.2003.
45. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 325(5940):617-20. doi:10.1126/science.1172747.
46. Amanna IJ, Raue HP, Slifka MK. Development of a new hydrogen-peroxide-based vaccine platform. Nat Med (2012) 18(6):974-9. doi:10.1038/nm.2763.
47. Battistoni A. Role of prokaryotic Cu,Zn superoxide dismutase in pathogenesis. Biochem Soc Trans (2003) 31(Pt 6):1326-9. doi:10.1042/bst0311326.
48. Ibarra JA, Steele-Mortimer O. Salmonella-the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol (2009) 11(11):1579-86. doi:10.1111/j.1462-5822.2009.01368.x.
49. Maier L, Vyas R, Cordova CD, Lindsay H, Schmidt TS, Brugiroux S, et al. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe (2013) 14(6):641-51. doi:10.1016/j.chom.2013.11.002.
50. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Muller AJ, Heikenwalder M, et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol (2005) 174(3):1675-85. doi:10.4049/jimmunol.174.3.1675.
51. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science (2010) 328(5975):228-31. doi:10.1126/science.1179721.
52. Hale JS, Ahmed R. Memory T follicular helper CD4 T cells. Front Immunol (2015) 6:16. doi:10.3389/fimmu.2015.00016.
53. Ilg K, Endt K, Misselwitz B, Stecher B, Aebi M, Hardt WD. O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect Immun (2009) 77(6):2568-75. doi:10.1128/IAI.01537-08.
54. Burniat W, Toppet M, De Mol P. Acute and recurrent Salmonella infections in three children with chronic granulomatous disease. J Infect (1980) 2(3):263-8. doi:10.1016/S0163-4453(80)90746-X.
55. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol (2007) 19(2):59-69. doi:10.1016/j.smim.2006.10.002.
56. Bauermeister LJ, Bowers JW, Townsend JC, McKee SR. Validating the efficacy of peracetic acid mixture as an antimicrobial in poultry chillers. J Food Prot (2008) 71(6):1119-22.
57. Rajkowski KT, Ashurst K. Use of 1% peroxyacetic acid sanitizer in an air-mixing wash basin to remove bacterial pathogens from seeds. Foodborne Pathog Dis (2009) 6(9):1041-6. doi:10.1089/fpd.2009.0267.
58. Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol (2012) 5(3):232-9. doi:10.1038/mi.2012.4.
59. Grover N, Dinu C, Kane R, Dordick J. Enzyme-based formulations for decontamination: current state and perspectives. Appl Microbiol Biotechnol (2013) 97(8):3293-300. doi:10.1007/s00253-013-4797-x.
60. Diard M, Garcia V, Maier L, Remus-Emsermann MN, Regoes RR, Ackermann M, et al. Stabilization of cooperative virulence by the expression of an avirulent phenotype. Nature (2013) 494(7437):353-6. doi:10.1038/nature11913.
61. Lycke N. Targeted vaccine adjuvants based on modified cholera toxin. Curr Mol Med (2005) 5(6):591-7. doi:10.2174/1566524054863898.
62. Thomson NR, Clayton DJ, Windhorst D, Vernikos G, Davidson S, Churcher C, et al. Comparative genome analysis of Salmonella enteritidis PT4 and Salmonella gallinarum 287/91 provides insights into evolutionary and host adaptation pathways. Genome Res (2008) 18(10):1624-37. doi:10.1101/gr.077404.108.
63. Nutter RL, Bullas LR, Schultz RL. Some properties of five new Salmonella bacteriophages. J Virol (1970) 5(6):754-64.
64. Schauer DB, Zabel BA, Pedraza IF, O'Hara CM, Steigerwalt AG, Brenner DJ. Genetic and biochemical characterization of Citrobacter rodentium sp. nov. J Clin Microbiol (1995) 33(8):2064-8.
65. Kinder SA, Badger JL, Bryant GO, Pepe JC, Miller VL. Cloning of the YenI restriction endonuclease and methyltransferase from Yersinia enterocolitica serotype O8 and construction of a transformable R-M+ mutant. Gene (1993) 136(1-2):271-5. doi:10.1016/0378-1119(93)90478-L.
66. Balmer ML, Slack E, de Gottardi A, Lawson MAE, Hapfelmeier S, Miele L, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med (2014) 6(237):ra66-66. doi:10.1126/scitranslmed.3008618.
67. Stecher B, Denzler R, Maier L, Bernet F, Sanders MJ, Pickard DJ, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A (2012) 109(4):1269-74. doi:10.1073/pnas.1113246109.
68. Unhanand M, Maciver I, Ramilo O, Arencibia-Mireles O, Argyle JC, McCracken GH, et al. Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis (1992) 165(4):644-50. doi:10.1093/infdis/165.4.644.
69. Haas A, Zimmermann K, Graw F, Slack E, Rusert P, Ledergerber B, et al. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut (2011) 60(11):1506-19. doi:10.1136/gut.2010.224774.